Linear chronic cutaneous graft-versus-host disease.
Kikuchi
A
A
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
Okamoto
S
S
Takahashi
S
S
Asano
S
S
Nishikawa
T
T
D000328:Adult; D001485:Basement Membrane / Q000473:pathology; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D019040:E-Selectin / Q000032:analysis; D004817:Epidermis / Q000473:pathology; D006086:Graft vs Host Disease / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007642:Keratosis / Q000473:pathology; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017512:Lichenoid Eruptions / Q000276:immunology* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation
D019040:E-Selectin; D007166:Immunosuppressive Agents; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D003561:Cytarabine; D018799:Intercellular Adhesion Molecule-1; D016572:Cyclosporine; D008727:Methotrexate